A detailed history of Gallagher Fiduciary Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Gallagher Fiduciary Advisors, LLC holds 3,065 shares of JNJ stock, worth $448,961. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,065
Previous 2,347 30.59%
Holding current value
$448,961
Previous $367,000 31.88%
% of portfolio
0.02%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $111,447 - $116,847
718 Added 30.59%
3,065 $484,000
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $33,488 - $36,542
-230 Reduced 8.93%
2,347 $367,000
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $63,701 - $71,362
409 Added 18.87%
2,577 $401,000
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $29,172 - $31,394
-189 Reduced 8.02%
2,168 $358,000
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $356,024 - $424,872
2,357 New
2,357 $365,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $383B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Gallagher Fiduciary Advisors, LLC Portfolio

Follow Gallagher Fiduciary Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gallagher Fiduciary Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gallagher Fiduciary Advisors, LLC with notifications on news.